Lotronex Tablet
Product Images NDC 83107-012

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lotronex (NDC 83107-012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Legacy Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Figure01)

Figure 1 (Figure01)
A bar chart comparing the percent of patients between placebo and LOTRONEX 1 mg twice daily groups across two sets of studies (Studies 1 & 2 and Studies 3 & 4). The chart shows a higher percentage of patients in the LOTRONEX groups for both study sets.*
FDA Label Image

Principal Display Panel (Lotronex 0.5 mg Bottle Label)

Principal Display Panel (Lotronex 0.5 mg Bottle Label)
Label for LOTRONEX (alosetron hydrochloride) tablets, 0.5 mg strength, oral dosage form. The label states that the package contains 30 film-coated tablets and that it is a prescription drug. The label includes a medication guide notice, storage instructions, and the manufacturer, Legacy Pharma USA Inc., Scottsdale, Arizona. The LOTRONEX logo and NDC 83107-013-30 are also present.*
FDA Label Image

Principal Display Panel (Lotronex 1 mg Bottle Label)

Principal Display Panel (Lotronex 1 mg Bottle Label)
LOTRONEX (alosetron hydrochloride) 1 mg oral tablets, packaged as 30 film-coated tablets. The label indicates federal law requires dispensing with a Medication Guide. It states the drug is prescription-only and includes storage instructions and distributor information: Legacy Pharma USA Inc., Scottsdale, AZ, made in Canada.*
FDA Label Image
FDA Label Image

Chemical Structure (Lotronex Structure)

Chemical Structure (Lotronex Structure)
Chemical structure diagram of alosetron hydrochloride, the active ingredient in LOTRONEX tablets. The diagram shows the molecular framework with labeled functional groups and atoms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.